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Abstract
Electronic  cigarette  use  is  particularly  prevalent  in  adolescents,  but  the
effects  of  secondhand  exposure  to  nicotine  vapor  in  adolescents  on  the
propensity  to  develop  nicotine  dependence  and  increase  nicotine  self-
administration in adulthood are poorly known. The present study explored
the  effects  of  nicotine  vapor  exposure  on  withdrawal-like  states
(hyperalgesia,  spontaneous  withdrawal  signs,  and  locomotor  activity)  in
adolescent  rats  and the vulnerability  to acquire  intravenous nicotine  self-
administration  in  adulthood.  Adolescent  (postnatal  day  38)  rats  were
exposed to intermittent nicotine vapor (14 h/day) for 7 consecutive days in a
range of  doses (0,  0.4,  and 7  mg/m3).  The rats  were  tested for  somatic,
emotional,  and  motivational  withdrawal  symptoms.  When  the  animals
reached  adulthood,  they  were  allowed  to  self-administer  nicotine  (0.03
mg/kg/0.1  ml)  intravenously  in  operant  chambers  for  1  h/day  for  12
consecutive  days. Rats  that  were  exposed  to  nicotine  vapor  presented
moderate to severe signs of spontaneous withdrawal after the cessation of
nicotine vapor. No effect on anxiety-like behavior was observed. Rats that
were exposed to high levels of nicotine vapor in adolescence had lower pain
thresholds  and  exhibited  faster  and  higher  acquisition  of  nicotine  self-
administration  in  adulthood. Chronic  exposure  to  nicotine  vapor  in
adolescent  rats  produced a  withdrawal-like  state  and  facilitated the
acquisition  of  intravenous nicotine  self-administration  in  adulthood.  These
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results suggest that exposure of adolescents to nicotine vapor may confer
higher risk of developing nicotine dependence when they become adults.
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Introduction
Electronic  cigarettes (e-cigarettes) are battery-operated devices that
are  designed  to  deliver  nicotine  through  vapor  instead  of  smoke.
Epidemiological population-based studies indicate that the rate of e-cigarette
use across countries is increasing among both current and former smokers
and  dramatically  increasing  among  nonsmokers,  particularly  among
adolescents  (https://www.drugabuse.gov/publications/drugfacts/electronic-
cigarettes-e-cigarettes; accessed July 7, 2019). Recent clinical data suggest
that  e-cigarette use is  most  appealing and prevalent  among adolescents.
Findings from the 2014 National Youth Tobacco Survey showed that current
e-cigarette use among high school students increased from 4.5% in 2013 to
13.4% in 2014, increasing from approximately 660,000 to 2 million students.
In fact, e-cigarette use has surpassed the use of every other tobacco product
overall,  including  conventional  cigarettes,  since  2011  to  date.  Nicotine
dependence  is  often  characterized  by  the  emergence  of  a  nicotine
abstinence syndrome after the cessation of chronic nicotine exposure. Such
an abstinence syndrome has been characterized in both humans and rats
and is associated with both somatic and motivational components (Shiffman
& Jarvik, 1976; Hughes et al., 1991; Malin et al., 1992; Malin et al., 1993;
Malin et  al.,  1994;  Hildebrand et  al.,  1997;  Epping-Jordan et  al.,  1998;
Watkins et al., 2000). In rats, the somatic signs of nicotine withdrawal (both
spontaneous withdrawal and withdrawal that is precipitated by the nicotinic
acetylcholine  receptor  [nAChR]  antagonist  mecamylamine)  include
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abdominal  constrictions,  facial  fasciculation,  ptosis,  and hyperalgesia.  The
motivational components include anxiety-like behavior and higher motivation
(craving) for nicotine  (Bruijnzeel,  2016). However, unclear are the ways in
which  adolescent  exposure  to  nicotine  vapor  affects  the  somatic  and
motivational aspects of nicotine dependence.
The first  goal  of  the present  study was to measure the effect  of  chronic
exposure  to  nicotine  vapor  on key behaviors  that  are  related to  nicotine
withdrawal  (somatic  signs,  hyperalgesia,  and  anxiety-like  behavior)  in
adolescent rats. The second goal was to test whether chronic exposure to
nicotine vapor during adolescence produces long-lasting changes that confer
greater  vulnerability  to  self-administer  intravenous  nicotine  in  adulthood.
Human studies have shown that the air concentrations of nicotine that are
emitted by various brands of  e-cigarettes range from 0.82 to 6.23 µg/m3
(Czogala et al., 2014). We tested the effects of two concentrations of nicotine
vapor (0.4 and 7 mg/m3) over 7 days of exposure (14 h/day).  Intermittent
nicotine vapor exposure, with 14 h vapor ON and 10 h OFF, was used based
on previous studies (Baiamonte et al., 2014; Gilpin et al., 2014; McGinn et
al., 2016; Xue et al., 2018) that showed that this protocol produces nicotine
dependence  with  somatic  signs  of  withdrawal  and  hyperalgesia  when
exposed to high levels of nicotine (7 mg/m3). This protocol is highly relevant
to adolescent e-cigarette users, who often vape intermittently  because of
either parental or societal restrictions. Withdrawal in rats peaks 16 h into
withdrawal but can be observed 10 h into withdrawal (Grieder et al., 2010).
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Our  overall  hypothesis  was  that  repeated  mild  withdrawal  (10  h)  is  an
important factor in the transition to addiction in both rats and humans, thus
this parameter is particularly important in the present study.
Materials and Methods
Animals
Male  Wistar  rats  (n =  18)  were  obtained  from  Charles  River
(Wilmington,  MA, USA)  1 week after their  weaning period (postnatal  day
[PND] 28). The rats weighed 120-150 g upon arrival in the laboratory. The
rats were tested during adolescence (PND 38-46; 200-220 g). Nicotine self-
administration  was performed during adulthood (PND 66-78;  300-330 g).
The animals were group housed (3 rats/cage) in standard cages in a room
with artificial lighting (12 h/12 h light/dark cycle, lights off at 8:00 AM) at a
constant  temperature  (20-22°C)  and  humidity  (45-55%) with  food  (2018
Teklad global 18% protein rodent diet; Teklad, Madison, WI, USA) and water
available ad libitum except during testing. The rats were handled twice for 5
min  after  arrival  in  the  animal  facility.  The  animal  procedures  met  the
guidelines of the National Institutes of Health and were approved by The
Scripps  Research  Institute  Institutional  Animal  Care  and  Use  Committee
(protocol no. 08-0015). All of the surgical procedures were performed under
isoflurane  anesthesia,  and  all  necessary  efforts were  made to  minimize
suffering of the animals.
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Nicotine vapor exposure
The rats (n = 6/group) were group housed in standard rat cages (3
rats/cage)  and  exposed  daily  from  9:00  AM  to  11:00  PM  to  intermittent
nicotine vapor (14 h ON/10 h OFF). Every cage had an air-tight transparent
Plexiglas lid. (-)Nicotine  (≥ 99%  [GS], 1.010 g/ml  liquid,  Sigma-Aldrich, St.
Louis, MO, USA) was used at 20°C. For the entire duration of nicotine vapor
exposure (14 h) and air exposure (10 h) for 7 consecutive days, the rats were
left undisturbed in the nicotine vapor chamber with food and water available
ad libitum. Nicotine vapor was produced as previously described (George et
al., 2010) to reach nicotine vapor concentrations of 0.4 and 7 mg/m3. The
nicotine:air ratio was 0:20 L/min for the air control group, 1:19 L/min for the
0.4 mg/m3 nicotine group, and 10:10 L/min for the 7.0 mg/m3 nicotine group.
Gas chromatography was used to analyze the level of nicotine in the test
chamber. A glass tube (70 mm length, 7 mm outer diameter) that contained
two sections of XAD-4 (front = 80 mg, back = 40 mg) that were separated by
silicate glass wool was used. The concentration (C) of nicotine was calculated
as the following: C = Wf  Wb  Bf  Bb / V (mg/m3 = g/L). Mass (μg) was
corrected for desorption efficiency (DE). Wf is the sample front of the sorbent
sections,  and  Wb is  the sample back of  the sorbent  sections,  and in  the
average media blank front (Bf) and back (Bb) sorbent sections. Air control
rats were treated similarly to nicotine-exposed rats, with the exception that
the air that entered the chambers did not contain nicotine.
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Withdrawal signs
After 7 days of  intermittent nicotine vapor exposure (14 h ON/10 h
OFF), the rats were maintained nicotine-free for 16-24 h and experienced
spontaneous withdrawal in their home cages. On the test day, after 16 h of
no exposure to nicotine  vapor,  the rats  were placed inside a transparent
cylinder (50 cm height   30 cm diameter) and observed for 30 min. The
number of wet dog shakes, front paw tremors, teeth chattering, genital licks,
and abdominal constrictions was counted. The sum of the observation scores
was  used  as  a  quantitative  measure  of  withdrawal  severity.  Three
experimenters who were blind to the treatment group scored the withdrawal
signs. The average of the three measures was used for the analyses.
Open field test
The open field test was performed at 16-24 h of nicotine abstinence
after 7 days of nicotine vapor exposure. Locomotor activity and anxiety-like
behavior were evaluated in an opaque open field apparatus (100 cm  100
cm   40  cm)  that  was  divided  into  20  cm   20  cm  squares.  On  the
experimental day, the animals were placed in the center of the open field,
and locomotor activity (number of lines crossed), time in the center, entries
into the center, and total distance traveled (in centimeters) were scored for
10  min.  Behavior  was  videotaped,  and  AnyMaze  software  was  used  to
analyze the recordings.
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Mechanical nociception in the von Frey test
Mechanical nociception was evaluated using the von Frey test. The test
was  first  performed  1  day  before  placing  the  animals  into  the  nicotine
exposure chamber to determine the baseline pain threshold of each rat. The
second test was conducted after 7 days of nicotine vapor exposure at 16-24
h of  nicotine  withdrawal  (immediately  after withdrawal  signs were scored
and the  locomotor  activity  test  was  performed).  The  hindpaw withdrawal
threshold was determined using von Frey filaments, ranging from 3.63 to
125.89 g (Edwards et al., 2012; Xue et al., 2018). A test session began after
10  min  of  habituation  to  the  testing  environment.  A  series  of  von  Frey
filaments were applied in ascending order from below a wire mesh to the
central region of the plantar surface of the left hindpaw, beginning with the
lowest filament (3.63 g). The filament was applied until buckling of the hair
occurred,  and  it  was  maintained  for  approximately  2  s.  A  withdrawal
response was considered valid  only  if  the  animal completely  removed  its
hindpaw from the mesh platform. The stimulus was incrementally increased
until a positive response was observed and then decreased until a negative
response was observed to determine a pattern of responses to apply to the
statistical method of Dixon (Dixon, 1980). The 50% paw withdrawal threshold
was  calculated  as  the  following:  Xf  +  kδ,  where  Xf is  the  last  von  Frey
filament employed,  k is the Dixon value that corresponds to the response
pattern, and  δ is the mean difference between stimuli.  Once the threshold
was  determined  for  the  left  hindpaw,  the  same  testing  procedure  was
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applied to the right hindpaw after 5 min.
Intravenous catheterization
Chronic intravenous jugular catheters were implanted in all of the rats
on PND 58 as described previously  (Caine  & Koob,  1993).  The  rats  were
anesthetized with 1-3% isoflurane in an oxygen mixture. Incisions were made
to  expose  the  right  jugular  vein.  A  catheter  that  was  made from Micro-
Renathane  tubing  (0.020  inches  inner  diameter; 0.037 inches  outer
diameter;  Braintree  Scientific,  Braintree,  MA,  USA)  was  subcutaneously
implanted. After insertion into the vein, the proximal end of the catheter was
anchored with surgical silk to the muscles under the vein. The distal end of
the catheter was attached to a stainless-steel cannula that was bent at a 90°
angle. The cannula was anchored in dental cement on the back of the rats.
For  1 week after  surgery,  the rats  were treated daily  with 0.2 ml  of  the
antibiotic  Cefazolin (262 mg/ml).  For the duration of the experiments, the
catheters were flushed daily with 0.2-0.3 ml of heparinized saline solution.
Body  weight  was  monitored  every  other  day.  Catheter  patency  was
confirmed at the end of the experiment with an injection of 0.2-0.3 ml of
Brevital sodium solution (10 mg/ml). Catheter patency was assumed if there
was an immediate loss of reflexes after the injection. The rats were given 1
week to recover from surgery before the self-administration experiments.
Operant training
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The  self-administration  chambers  consisted  of  operant  conditioning
chambers (Med Associates, St. Albans, VT, USA) that were enclosed in sound-
attenuating, ventilated environmental cubicles. Each chamber was equipped
with two retractable levers that were located in the front panel.  A plastic
tube  that  was  connected  to  the  catheter  before  beginning  the  session
delivered nicotine. An infusion pump was activated by responses on the right
(“active”) lever, and responses on the left (“inactive)” lever were recorded
but did not result in any programmed consequences. Activation of the pump
resulted in the delivery of 0.1 ml of nicotine solution (0.03 mg/kg/0.1 ml) on
a  fixed-ratio 1  (FR1)  schedule  of  reinforcement  for  1  h,  paired  with
illumination of the chamber by the cue light. The delivery of nicotine solution
was  followed  by  a  20-s  timeout  (TO)  period, during  which  further  lever
presses did not result in any consequences. Nicotine solution was prepared
fresh every other day from (-)nicotine hydrogen tartrate salt (Sigma-Aldrich)
based on the animals’ body weight, and the pH was adjusted to 7.3 with 1 M
NaOH.
Experimental design
The experimental design is summarized in Fig. 1. Adolescent rats (PND
37) were subjected to the von Frey test prior to the behavioral tests so that
we could perform within-subjects analyses, based on the known between-
subjects  variability  in  pain  thresholds  in  rats. The  animals  were  equally
divided into three groups (n = 6/group). They were placed in the nicotine
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vapor  chambers  and  exposed  daily  to  intermittent  nicotine  vapor  (14  h
ON/10 h OFF). Body weight was recorded every other day. After 7 days of
intermittent  nicotine  exposure,  the  animals  were  returned  to  their  home
cages in the animal facility.  Withdrawal scores, including teeth chattering,
paw tremors, genital licking, wet-dog shakes, and abdominal constrictions,
were recorded after 16 h of spontaneous withdrawal for 30 min starting at
3:00 PM the next day. After the assessment of somatic withdrawal signs,
locomotor  activity  was  assessed in  a  10  min  test  at  16-24  h  of  nicotine
withdrawal. The total distance traveled, number of entries into the central
zone  of  the  arena,  and  time  spent  in  the  central  zone  were  recorded.
Immediately  after  scoring  spontaneous  withdrawal  signs  and  evaluating
locomotor activity, the von Frey test was performed. On PND 58, the rats
underwent intravenous catheter implantation surgery. They were allowed to
recover for 1 week after surgery. Starting on PND 66, the rats were given
daily  1-h  access  to  nicotine  self-administration  (0.03  mg/kg/0.1ml)  for  12
consecutive days.
Statistical analysis
The data were analyzed using mixed-factorial or one-way analysis of
variance  (ANOVA),  followed  by  the  Newman-Keuls  post  hoc test  when
appropriate. For individual means comparisons, Student’s paired or unpaired
t-test  was  used.  Data  from  the  mechanical  nociception  test  during
spontaneous withdrawal were analyzed using Student’s t-test by comparing
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the withdrawal results with the rats’ baselines during the naive state. Values
of p < 0.05 were considered statistically significant.
Results
Vapor exposure induced nicotine dependence in adolescent rats
The animals that were exposed to the highest concentration of nicotine
vapor exhibited significant body weight loss compared with rats that were
exposed to air and the low concentration of  nicotine vapor (Fig.  2a).  The
mixed-factorial ANOVA, with group (passive nicotine dose) as the between-
subjects factor and time as the within-subjects factor, revealed main effects
of group (F2,15 =  34.2,  p < 0.001) and time (F3,15  =  17.73,  p < 0.001) and a
significant  group   time  interaction  (F6,45 =   17.434;  p  <  0.001).  The
Newman-Keuls post hoc test showed that rats that were exposed to the high
concentration of nicotine vapor (7 mg/m3) exhibited a significant loss of body
weight  on  day  3  (p  < 0.05),  day  5  (p <  0.01),  and  day  7  (p <  0  .01)
compared with the air-exposed group.
Rats that were exposed to the highest concentration of nicotine vapor
exhibited  a  decrease  in  mechanical  thresholds  during  spontaneous
withdrawal (t5 = 3.8, p < 0.01) relative to their own baseline pain threshold
that was established prior to nicotine vapor exposure (from 46.7 ± 7.1 g to
21.5 ± 4.3 g; Fig. 2b). The one-way ANOVA revealed that 7-day exposure to
intermittent  nicotine  vapor  significantly  increased pain  sensitivity  (F2,15   = 
5.73,  p  < 0.05) during nicotine withdrawal. Rats that were exposed to the
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highest concentration of nicotine vapor (7 mg/m3) were more sensitive to
pain (p < 0.05) compared with air-exposed rats. The number of spontaneous
withdrawal signs, measured 16-24 h after the cessation of nicotine vapor, is
shown  in  Fig.  2c.  The  one-way  ANOVA  revealed  that  7-day  exposure  to
nicotine  vapor  induced significant spontaneous withdrawal  signs after  the
discontinuation of intermittent nicotine vapor (F2,15   =  10,  p  < 0.0013). The
Newman-Keuls  post  hoc test  showed that  both  concentrations  of  nicotine
vapor (0.04 and 7 mg/m3) significantly increased withdrawal scores (p < 0.05
and p < 0.01, respectively) compared with air-exposed rats.
Effect of nicotine vapor withdrawal on anxiety-like behavior
Immediately  after  the  assessment  of  somatic  withdrawal  signs,
locomotor activity was recorded over a 10-min period (Fig. 3). The  ANOVA
revealed a nonsignificant trend toward an overall difference in the time spent
in the center (F2,15  =  0.36, p = 0.7; Fig. 3a), number of entries into the center
(F2,15  =  2.52, p = 0.11; Fig. 3b), and total distance traveled (F2,15  =  3.43, p =
0.059; Fig. 3c) between the air- and nicotine-exposed groups. A trend toward
a  decrease  in  the  number  of  entries  into  the  center  and  total  distance
traveled  was  observed  in  nicotine-withdrawn  animals  compared  with  air-
exposed controls.
Effect of nicotine vapor exposure during adolescence on intravenous nicotine
self-administration during adulthood
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After  completing  the  first  set  of  experiments,  the  rats  were  left
undisturbed  in  their  home  cages  in  the  animal  facility.  On  PND  58,  the
animals were implanted with intravenous catheters to assess nicotine self-
administration.  After  1  week of  recovery  from surgery,  the  animals  were
placed in  operant  chambers  and allowed to self-administer  nicotine  (0.03
mg/kg/0.1 ml) in 1 h daily sessions. Animals that were previously exposed to
the highest concentration of nicotine (7 mg/m3) during adolescence exhibited
higher  nicotine  intake  during  adulthood  compared  with  rats  that  were
exposed to air or low-concentration nicotine vapor during adolescence (Fig.
4a). The mixed-factorial ANOVA, with group (passive nicotine dose) as the
between-subjects  factor  and  time  as  the  within-subjects  factor,  revealed
main effects of group (F2,15  =  3.98,  p < 0.05) and time (F10,15  =  3.88,  p  <
0.001) but no group   time interaction (F20,150  =  0.32,  p > 0.05). The one-
way  ANOVA  showed  that  total  nicotine  intake  over  the  12  sessions  of
intravenous  nicotine  self-administration  was  higher  in  animals  that  were
previously exposed to 7 mg/m3 nicotine vapor during adolescence (F2,15   = 
15.49, p < 0.0001; Fig. 4b). The Newman-Keuls post hoc test revealed that
rats  that  were  exposed  to  7  mg/m3 nicotine  vapor  during  adolescence
exhibited higher intravenous nicotine intake in adulthood compared with the
air-exposed group (p < 0.001).
Discussion
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The present study evaluated the effects of nicotine vapor exposure on
withdrawal-like  states  in  adolescent  rats  and  the  propensity  to  initiate
intravenous nicotine  self-administration in  adulthood.  Chronic  exposure to
0.4  mg/m3 nicotine  vapor  during  adolescence  increased  somatic  signs  of
nicotine withdrawal but was not associated with hyperalgesia, anxiety-like
behavior,  or  the  vulnerability  to  self-administer  nicotine  in  adulthood.
Chronic exposure to 7 mg/m3 nicotine vapor during adolescence increased
somatic  signs  of  nicotine  withdrawal  and increased hyperalgesia  and the
vulnerability to intravenously self-administer nicotine in adulthood. 
We first tested whether intermittent exposure to low or high levels of 
nicotine vapor for 7 days in adolescent rats produces nicotine dependence. 
Withdrawal from nicotine induces somatic signs of withdrawal and negative 
affect in humans, leading to bradycardia, insomnia, gastrointestinal 
discomfort, increased appetite, weight gain, irritability, depressed mood, 
restlessness, anxiety, increased stress, and craving for tobacco (Hughes et 
al., 1991; Kallupi & George, 2017). In rodents, the cessation of nicotine 
administration or administration of nAChR antagonists in rats that are 
chronically exposed to nicotine results in the emergence of somatic signs of 
nicotine withdrawal, including abdominal constrictions, facial fasciculation, 
increased eye blinks, and ptosis (Malin et al., 1992; Malin et al., 1994; 
Hildebrand et al., 1997; Epping-Jordan et al., 1998). Our results showed that 
nicotine vapor exposure at levels that are sometimes observed in 
environments that allow prolonged and high secondhand exposure to 
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tobacco or e-cigarettes (Pellegrino et al., 2012; Evans & Hoffman, 2014; 
Schroeder & Hoffman, 2014) produced nicotine dependence, reflected by the
emergence of spontaneous somatic signs of withdrawal. Notwithstanding the
slight possibility that a fraction of nicotine was absorbed through the skin, 
toxicological studies have demonstrated that skin absorption represents less 
than 10% of the total dose that is received from combined skin and 
inhalation exposure (Hayes & Bakand, 2010). These results are consistent 
with our previous findings (George et al., 2010) and further demonstrate that
1 week of exposure to nicotine vapor (0.4 mg/m3) is sufficient to produce 
mild signs of nicotine dependence in adolescent rats. We also observed a 
significant reduction of body weight and pronounced hyperalgesia in rats 
that were exposed to a high level of nicotine compared with rats that were 
exposed only to air or a low level of nicotine, suggesting that the high 
nicotine concentration resulted in a greater level of dependence, similar to 
observations in heavy smokers (Shiffman & Paty, 2006; Scheuermann et al., 
2015). This finding is consistent with other studies that showed that high 
doses of nicotine reduce appetite and alter feeding patterns, typically 
resulting in a decrease in body weight (Grunberg, 1986; Grunberg et al., 
1986; Blaha et al., 1998; Miyata et al., 1999; Bray, 2000; Zhang et al., 2001).
No significant alterations of locomotor activity were observed in the 
open field test. One possible explanation is that withdrawal symptoms may 
have interfered with measures of locomotor activity, such as entries in the 
center zone and total distance traveled. Compared with nicotine-naive rats, 
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nicotine-tolerant rats develop greater mechanical hyperalgesia. Clinically, 
long-term smokers have a higher risk of suffering chronic pain (Ditre et al., 
2011; Fishbain et al., 2013; Baiamonte et al., 2014; Cohen et al., 2015). Our 
data are consistent with our previous studies that reported the development 
of hyperalgesia in nicotine-dependent rats with extended access to nicotine 
self-administration (George et al., 2010; Cohen & George, 2013; Cohen et al.,
2015). A few clinical studies have provided preliminary evidence that e-
cigarettes may serve as a smoking cessation aid. These studies reported the 
alleviation of craving and a decrease in nicotine withdrawal symptoms over 
time when these devices are used as substitutes for regular tobacco 
cigarettes (Dawkins et al., 2015; Lechner et al., 2015; Malas et al., 2016). 
However, more studies are needed to establish the long-term effects of the 
cessation of e-cigarette use. Unclear is whether e-cigarette use in 
adolescence produces dependence in humans. Several studies have 
investigated potential differences in nicotine intake and relapse during 
adolescence and adulthood using established rat models of nicotine self-
administration (Shram et al., 2008). Other studies have examined the 
rewarding properties of nicotine in adolescents compared with adults using 
conditioned place preference and conditioned taste aversion procedures
(Vastola et al., 2002; Belluzzi et al., 2004; Torrella et al., 2004; Shram et al., 
2006). Several studies have reported that adolescent rats may acquire 
nicotine self-administration faster than adult rats (Belluzzi et al., 2005; 
Levin et al., 2007) but one caveat of these studies is that they used 
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different routes of administration. The present results demonstrate that 1 
week of exposure to a wide range of concentrations of nicotine vapor (0.4-7 
mg/m3) is sufficient to produce nicotine dependence. Such behavioral 
changes may contribute to the maintenance and progression of e-cigarette 
use through a mechanism of negative reinforcement.
One limitation of the present study was that the blood nicotine levels 
was not measured. However, we previously reported that this level of 
nicotine exposure leads to blood nicotine levels in the 10-100 ng/ml range
(George et al., 2010; Gilpin et al., 2014). Air nicotine concentrations in the 1-
10 mg/m3 range closely mimic conditions of human smoking. Moreover, 
other groups (Baiamonte et al., 2014; McGinn et al., 2016; Xue et al., 2018) 
have replicated our original findings, showing that the delivery of 7 mg/m3 
nicotine at 10 L/min produced nicotine dependence with somatic signs of 
withdrawal and hyperalgesia, similar to other animal models (e.g., 
minipumps and intravenous self-administration), and blood nicotine levels in 
the 10-100 ng/ml range. Another limitation of the present study was that we 
included male adolescent rats only. Further studies in females and human 
studies are needed to clarify the effect of e-cigarette use on nicotine 
dependence in adolescence.
In a previous study, we found that chronic intermittent nicotine vapor
inhalation  produced  the  escalation  of  nicotine  self-administration  and
physical dependence in adult rats  (Gilpin et al., 2014). However, the long-
term consequences of adolescent exposure to nicotine vapor on intravenous
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self-administration in adulthood has not  been  previously investigated. The
present results showed that exposure to high levels of nicotine (7 mg/m3)
during adolescence facilitated the acquisition of  intravenous nicotine self-
administration in adulthood compared with rats that were exposed only to air
or  low nicotine  levels.  These results  suggest that adolescent  exposure to
high-dose  nicotine  can  either  increase  the  positive  reinforcing  effects  of
nicotine or increase the negative reinforcing effects of withdrawal.
In summary, the present study demonstrated that chronic exposure to
nicotine  vapor  in  adolescence  produced  a  withdrawal-like  state  and
facilitated  the  acquisition  of  intravenous  nicotine  self-administration  in
adulthood. Secondhand exposure to e-cigarettes that contain high levels of
nicotine may have long-term consequences on the vulnerability to develop
nicotine dependence and the motivation for nicotine. Future animal studies
will elucidate  the  neurobiological  changes  that  are  associated  with
secondhand exposure to e-cigarettes.
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Figure Legends
Figure  1.  Timeline  of  the  experiments  and  representative  schematic
diagram of the nicotine vapor machine.
Figure 2. (a) Body weight of rats that were exposed to air (0.0 mg/m3) and
nicotine vapor (0.4 and 7 mg/m3). *p < 0.05, ***p < 0.001, compared with
day  1;  #p <  0.05,  ##p <  0.01,  difference  between  air-exposed  rats  and
nicotine (7 mg/m3)-exposed rats on days 3, 5, and 7. (b) Pain thresholds. The
data  are  expressed  as  a  percent  difference  from  baseline.  **p <  0.01,
significant decrease in pain thresholds in nicotine (7 mg/m3)-exposed rats
compared with their own baseline; #p < 0.05, difference between nicotine (7
mg/m3)-exposed  rats  and air-exposed  rats.  (c)  Spontaneous  withdrawal
symptoms. *p < 0.05, **p < 0.01, compared with air-exposed rats.
Figure 3. Open field test. (a) Time in center. (b) Entries into center. (c) Total
distance traveled. No significant differences were observed between groups.
Figure 4. Intravenous nicotine self-administration in adulthood. (a) Number
of nicotine rewards in 1 h sessions over 12 consecutive days. (b) Average
number of nicotine rewards in air-exposed and nicotine-exposed rats. ***p <
0.001,  compared  with  air-exposed  rats.  (c)  Inactive  lever  responses.  No
differences were observed between groups.
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